The phyllodes menace-Variation in course, therapy, and appearance of phyllodes tumors in a case series of three patients

被引:0
作者
Schiltz, Daniel [1 ]
Sokolow, Alexander Jan [1 ]
Minck, Natalya [2 ]
Schreml, Stephan [3 ]
Moser, Lutz [4 ]
von Fritschen, Uwe [1 ,5 ]
机构
[1] Helios Hosp Emil Von Behring, Dept Plast & Aesthet Surg, Hand Surg, Berlin, Germany
[2] HELIOS Hosp Emil Von Behring, Dept Pathol, Berlin, Germany
[3] Univ Hosp Regensburg, Dept Dermatol, Regensburg, Germany
[4] Helios Hosp Emil Von Behring, Dept Radiotherapy, Berlin, Germany
[5] Helios Hosp Emil Von Behring, Dept Plast & Aesthet Surg, Hand Surg, Walterhoferstr 11, D-14165 Berlin, Germany
来源
CLINICAL CASE REPORTS | 2023年 / 11卷 / 09期
关键词
breast cancer; breast tumors; cystosarcoma phyllodes; PRIMARY SURGICAL-TREATMENT; RECEPTORS EXPRESSION; BREAST; RECURRENCE; FIBROADENOMA; GRADE; CELLS;
D O I
10.1002/ccr3.7836
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Key Clinical MessageEarly and complete surgical resection is the most important therapeutic and diagnostic measure. Adjuvant radiation is suggested for malign phyllode tumors, phyllode tumors larger than 10 cm or those with a low distance to the resection margins.AbstractPhyllodes tumors are rare fibroepithelial tumors of the breast. Histologically, they are usually classified as benign, borderline or malignant, though these classifications do not necessarily reflect the clinical course of the disease. These tumors may stay undetected for years, or show sudden and rapid progression. There is currently no consistent therapy recommendation based upon histological findings, the localization of the tumor and/or whether it is recurrent. Using the examples of three patients, we show how courses and therapy may differ widely, and discuss this in the context of the current state of the literature. 58 year old patient presenting with borderline phyllodes tumor.image
引用
收藏
页数:8
相关论文
共 41 条
  • [1] Current Trends in the Management of Phyllodes Tumors of the Breast
    Adesoye, Taiwo
    Neuman, Heather B.
    Wilke, Lee G.
    Schumacher, Jessica R.
    Steiman, Jennifer
    Greenberg, Caprice C.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (10) : 3199 - 3205
  • [2] Risk factors for recurrence and death after primary surgical treatment of malignant phyllodes tumors
    Asoglu, O
    Ugurlu, MM
    Blanchard, K
    Grant, CS
    Reynolds, C
    Cha, SS
    Donohue, JH
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (11) : 1011 - 1017
  • [3] BERNSTEIN L, 1993, CANCER-AM CANCER SOC, V71, P3020, DOI 10.1002/1097-0142(19930515)71:10<3020::AID-CNCR2820711022>3.0.CO
  • [4] 2-G
  • [5] Relative frequency and morphology of cancers in carriers of germline TP53 mutations
    Birch, JM
    Alston, RD
    McNally, RJQ
    Evans, DGR
    Kelsey, AM
    Harris, M
    Eden, OB
    Varley, JM
    [J]. ONCOGENE, 2001, 20 (34) : 4621 - 4628
  • [6] BLICHERTTOFT M, 1975, SURG GYNECOL OBSTET, V140, P929
  • [7] A Subset of Malignant Phyllodes Tumors Express p63 and p40 A Diagnostic Pitfall in Breast Core Needle Biopsies
    Cimino-Mathews, Ashley
    Sharma, Rajni
    Illei, Peter B.
    Vang, Russell
    Argani, Pedram
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (12) : 1689 - 1696
  • [8] Grabowski J, 2007, AM SURGEON, V73, P967
  • [9] Hanby A M., 2004, Breast Cancer Res, V6, P133, DOI DOI 10.1186/BCR788
  • [10] Successful Preoperative Chemoembolization in the Treatment of a Giant Malignant Phyllodes Tumor
    Hashimoto, Kazuki
    Mimura, Hidefumi
    Arai, Yasunori
    Doi, Masatomo
    Kojima, Yasuyuki
    Tsugawa, Koichiro
    Nakajima, Yasuo
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2016, 39 (07) : 1070 - 1075